These results suggest that elevated UPRmt is a poor prognosis factor for LAUD patients, consistent with the roles of UPRmt in mediating Maf1 regulation of IR toxicity in A549 lung cancer cells. The gene discussed is MAF1; the disease is lung carcinoma.